Akari Therapeutics PLC (AKTX) — SC 13D Filings

All SC 13D filings from Akari Therapeutics PLC. Browse 2 Activist Stake Filing reports with AI-powered summaries and risk analysis.

SC 13D Filings (2)

Theofilos Charles Steve reports 1.9% stake in Akari Therapeutics — Jun 18, 2024 Risk: medium
On May 31, 2024, Theofilos Charles Steve filed a Schedule 13D for Akari Therapeutics Plc, reporting beneficial ownership of 1,000,000 ordinary shares, represent
Patel Discloses 1.9% Stake in Akari Therapeutics — Jun 7, 2024 Risk: medium
On May 31, 2024, Samir Rashmikant Patel filed a Schedule 13D for Akari Therapeutics Plc, reporting beneficial ownership of 1,000,000 ordinary shares, representi

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX